Health sharing, a viable option for health care

Photo Credit: Linos Garsys/ The Washington Times

When it comes to the intense (and intensifying) debate over health care in America, the conversation begins at the top of the alphabet. “A” is for “Access.”

One of the key lessons we’ve learned from the Obamacare experience is that “having health insurance” isn’t the same thing as having access to quality health care.

Millions of Americans are learning the hard way about the tradeoffs between health insurance policies that have no premiums (so-called “free health care”) or those with low premiums but high out-of-pocket costs. The dual promises of “free health care” and the ability to “keep your existing insurance if you want to” were quickly proven to be mere political slogans with no basis in reality.

“The truth,” as Oscar Wilde quipped, “is rarely pure and never simple.” Nowhere is this truer than when it comes to insurance design. Americans are understandably “B” (baffled) about their lack of “C” (choice).

Broader access comes via expanded choice. Some believe average citizens can’t be allowed to choose their health coverage. These are the same voices who initially decried the Medicare Part D drug benefit because seniors couldn’t possibly choose the plan that was best for them. Today Part D has a 90 percent approval rating among those 65 and older.

In August 2018, the Trump administration finalized rules that expand access to so-called “skinny” short-term health insurance plans. These are low-cost, low-coverage options designed for healthy young people — among others — who chose to opt out of Obamacare. They instead prefer to pay the mandated fine, which is generally lower than the price of even a low-cost Obamacare “bronze” level policy.
 
 
Sign Up for Our Email Newsletter

RECENT NEWS

Zeroing Out Drug Prices

Zeroing Out Drug Prices

There are some tough but important basic principles when it comes to innovation in health care technologies....  Read more

Elizabeth Warren's Threat to Medical Progress

Elizabeth Warren's Threat to Medical Progress

Senator Elizabeth Warren (D-MA) mistakenly believes that pharmaceutical innovation is primarily driven by the National In...  Read more

FDA and Juul E-Cig Regs Should Keep Anti-Smoking Zealots at Bay

FDA and Juul E-Cig Regs Should Keep Anti-Smoking Zealots at Bay

E-cigarettes have helped millions of Americans quit smoking. And they have helped millions more reduce their consumption....  Read more

DRUGWONKS BLOG